Therapeutic approaches to employ monoclonal antibody for cancer treatment

Salonee Martins, Purva Salvi, Sai Tejaswi Lavuri, Manjita Srivastava, Shalini Sakthivel, Muneesh Kumar Barman, Kailash Chand, Meenakshi Singh, Subash C. Sonkar, Prudhvilal Bhukya

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

1 Scopus citations

Abstract

With the evolution of the tissue system and division of function among differentiated cells/tissues, the property of controlled cell growth also evolved in animals. It is when this very control is lost that cancers develop. The immune system's ability to distinguish between self and non-self is central to impeding cancer progression. However, cancer cells in time can develop multiple ways of escaping immune control. Even today, cancer remains a disease of baffling complexity on account of its diverse originand pathogenesis. Classical methods like surgery, radiation, and chemotherapy have failed to make the cut as idyllic therapy, especially considering the encumbering side-effects and high failure rate. Alternative therapeutic strategies that exploit the immune system itself have proved promising. One of these is monoclonal antibody therapy. In this chapter, the relationship between the immune system and cancer and various forms of immunotherapy are discussed in detail.

Original languageEnglish
Title of host publicationHandbook of Research on Advancements in Cancer Therapeutics
PublisherIGI Global
Pages42-88
Number of pages47
ISBN (Electronic)9781799865315
ISBN (Print)1799865304, 9781799865308
DOIs
StatePublished - 27 Nov 2020
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Therapeutic approaches to employ monoclonal antibody for cancer treatment'. Together they form a unique fingerprint.

Cite this